CPhI Japan

Activities: Recruitment Ingredients Regulatory Digital Pharmaceutical Logistics

Trending Articles

  1. AmMax Bio licenses antibody-drug conjugate technology for haematological cancers from Lonza New agreement provides AmMax with access to Lonza’s GlycoConnect, HydraSpace, and SYNtecan linker-payload technologies | Agreement to target development of novel...
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Where nanoengineering meets drug formulation How Nanexa is turning short-acting drugs into long-acting injectables
  3. IMA MED-TECH launches ASSEMBLA modular assembly platform for medical devices across full lifecycle The engineer-to-order system scales from 20 to 500+ parts per minute on a single extendable frame, supporting injectables, inhalers, diagnostics and wearables from clinical...
  4. ACG Packaging Materials gains ISO 9001 and EN ISO 15378 certification for Croatia facility The dual-certified warehouse and slitting site strengthens ACG's European supply chain offer, bringing primary packaging materials production closer to customers amid growing...
  5. Why integrated outsourcing wins in modern drug development Aligning drug substance and drug product development within a single outsourcing model accelerates timelines, sharpens CMC decisions and reduces risk by enabling parallel...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

Finance
Deprecated Yen attracting renewed international interest in Japanese pharma

Deprecated Yen attracting renewed international interest in Japanese pharma

Half of all exhibitors at CPHI Japan are international as business links strengthen with Switzerland, Korea, USA and the UK
Manufacturing
Japan produces highest quality APIs, CPhI data says

Japan produces highest quality APIs, CPhI data says

Several COVID vaccines are approaching commercial launch in Japan, coinciding with an ongoing biosimilars boom
Research & Development
CPhI Japan: Internationalisation reaches new heights

CPhI Japan: Internationalisation reaches new heights

Innovation in the country, driven by structural and and regulatory changes, has promoted both inbound and outbound collaboration
Finance
Pricing system reform and generics trend apparent at CPhI Japan 2018

Pricing system reform and generics trend apparent at CPhI Japan 2018

After recent changes in Japan, which is known to be an innovative drug market, an increase in international generic API companies and suppliers has been reported at next month’s CPhI Japan 2018
Media
CPhI Japan predicts a transformative year for Japanese pharma

CPhI Japan predicts a transformative year for Japanese pharma

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma, as the market evolves towards growth in generics, biosimilars and increased internationalisation
Pharmaceutical
CPhI Japan to explore changes in generics and OTC

CPhI Japan to explore changes in generics and OTC

Growing market for generics and liberalisation of OTC medicines driving demand at CPhI Japan
Manufacturing

CPhI Japan

20 - 22 April 2016, Exhibition, Tokyo, Japan
Subscribe now